These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721 [TBL] [Abstract][Full Text] [Related]
3. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262 [TBL] [Abstract][Full Text] [Related]
4. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730 [TBL] [Abstract][Full Text] [Related]
5. Identification of Nine M6A-Related Long Noncoding RNAs as Prognostic Signatures Associated with Oxidative Stress in Oral Cancer Based on Data from The Cancer Genome Atlas. Shan L; Lu Y; Song Y; Zhu X; Xiang CC; Zuo ED; Cheng X Oxid Med Cell Longev; 2022; 2022():9529814. PubMed ID: 35910847 [TBL] [Abstract][Full Text] [Related]
6. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
8. m6A-Mediated Xiao Y; Zhu X; Li Q; Wang Z; Zuo Q; Liu X; Tan J Front Biosci (Landmark Ed); 2024 Jul; 29(7):257. PubMed ID: 39082352 [TBL] [Abstract][Full Text] [Related]
9. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis. Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652 [TBL] [Abstract][Full Text] [Related]
10. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma. Sun Z; Jing C; Xiao C; Li T; Wang Y Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247 [TBL] [Abstract][Full Text] [Related]
11. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m Wang X; Zhi M; Zhao W; Deng J IUBMB Life; 2024 Jul; 76(7):437-450. PubMed ID: 38265150 [TBL] [Abstract][Full Text] [Related]
12. A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis. Yang Q; Cheng C; Zhu R; Guo F; Lai R; Liu X; Li M Oral Oncol; 2022 Apr; 127():105771. PubMed ID: 35189585 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of the prognosis and biological significance of N6 methyladenine regulators in oral squamous cell carcinoma. Yu M; Shen F; Li X; Zhu C; Pei Y; Zhang M; Xiao W J Gene Med; 2024 Jan; 26(1):e3619. PubMed ID: 37985224 [TBL] [Abstract][Full Text] [Related]
14. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
15. Consensus clustering and novel risk score model construction based on m6A methylation regulators to evaluate the prognosis and tumor immune microenvironment of early-stage lung adenocarcinoma. He M; Zhi Y; Li C; Zhao C; Yang G; Lv J; You H; Huang H; Cao X Aging (Albany NY); 2024 Jul; 16(14):11318-11338. PubMed ID: 39028290 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782 [TBL] [Abstract][Full Text] [Related]
17. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions. Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P Cells; 2020 Aug; 9(8):. PubMed ID: 32756466 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics. Zhang YY; Mao MH; Han ZX Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632 [TBL] [Abstract][Full Text] [Related]
19. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway. Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885 [TBL] [Abstract][Full Text] [Related]
20. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma. Wang Z; Cheng H; Xu H; Yu X; Sui D Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]